Seer, Sciex to provide end-to-end proteomics solutions

By The Science Advisory Board staff writers

March 30, 2021 -- Sciex and Seer have inked a nonexclusive commercial agreement. Under the deal, Seer will market Sciex's mass spectrometry systems together with its Proteograph product suite.

The firms believe that the combination will yield end-to-end proteomics workflows for labs of all types. Seer's Proteograph product suite includes proprietary engineered nanoparticles, consumables, an automation instrument, and software that enables proteomics studies.

Adding Sciex systems will bring new options for customers to add unbiased proteomics analysis to their studies, according to the companies. Existing proteomics labs can also expand their application set with the combined offering, Seer and Sciex said.

Sciex acquires Intabio
Sciex has acquired Intabio, developer of the Blaze system for biotherapeutic analysis and quality assessment. The Blaze system enables direct coupling...
Sciex, 908 Devices launch biotherapeutics characterization platform
Sciex and 908 Devices have made the ZipChip platform for Sciex mass spectrometers available to the public. This platform expands mass spectrometers from...

Copyright © 2021

Interphex 2021
October 19-21
New York City, New York United States
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter